FDA Adverse Event Summary report: N

FMP HIP

MDR report key: 3000255 · Received March 12, 2013

Report

Report Number
1644408-2013-00141
Date Received
March 12, 2013
Date of Event
February 28, 2013
Report Date
February 28, 2013
Manufacturer
ENCORE MEDICAL, L.P.
Product Code
KWA
PMA / PMN Number
K040354
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

THE REASON FOR THIS REVISION SURGERY WAS IDENTIFIED AS DISLOCATION AFTER TEN DAYS OF PATIENT USE. THE OUTCOMES ATTRIBUTED TO THIS EVENT ARE REQUIRED INTERVENTION TO PREVENT PERMANENT IMPAIRMENT/DAMAGE. THERE IS NO INFORMATION IN THIS COMPLAINT ABOUT ANY PATIENT INJURIES, ACTIVITIES, ACCIDENTS, OR MEDICAL CONTRAINDICATIONS THAT MAY HAVE CONTRIBUTED TO THE REVISION SURGERY. THERE WAS NO DELAY IN SURGERY AND ANOTHER SUITABLE DEVICE WAS AVAILABLE FOR USE. THE REVISION SURGERY WAS COMPLETED AS INTENDED. THE DEVICE WAS NOT RETURNED TO DJO SURGICAL FOR EXAMINATION. A REVIEW OF THE DEVICE HISTORY RECORDS SHOWED NO NON-CONFORMING MATERIAL REPORTS ASSOCIATED WITH THIS PRODUCT. (B)(4). THE ROOT CAUSE FOR THE DISLOCATION WAS NOT DETERMINED WITH CONFIDENCE. THERE IS NO INFORMATION REPORTED THAT SHOWED A MATERIAL, DESIGN, OR MANUFACTURING PROBLEMS WITH THE PRODUCT. SEVERAL FACTORS NOT RELATED TO THE IMPLANT CAN PLAY A ROLE IN DISLOCATION SUCH AS; LOOSE JOINT FROM INADEQUATE SOFT TISSUE AND PATIENT ACTIVITY.

Description of Event or Problem · 1

REVISION SURGERY - THE PATIENT'S HIP DISLOCATED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
103597 FMP HIP COCR HEAD KWA ENCORE MEDICAL, L.P. 638C1046

Patients

Seq Age Sex Outcome Treatment
1 70 YR Required Intervention 411-00-350, LOT 931B1037